HONG KONG/BEIJING, Jan 6 (Reuters) – China is in talks with Pfizer Inc. (PFE.N) to obtain a license that will allow domestic drugmakers to manufacture and distribute a generic version …
HONG KONG/BEIJING, Jan 6 (Reuters) – China is in talks with Pfizer Inc. (PFE.N) to obtain a license that will allow domestic drugmakers to manufacture and distribute a generic version …